Human Growth Hormone and Tumor Cell Death
Author Information
Author(s): Cherbonnier C, Déas O, Carvalho G, Vassal G, Dürrbach A, Haeffner A, Charpentier B, Bénard J, Hirsch F
Primary Institution: INSERM U542/Paris XI University, Villejuif Cedex, France
Hypothesis
Does human growth hormone (hGH) enhance tumor cell apoptosis through glutathione production and decreased NF-κB activity?
Conclusion
The study found that hGH sensitizes tumor cells to apoptosis induced by TNF-α by decreasing NF-κB activity and increasing glutathione levels.
Supporting Evidence
- hGH increased the percentage of dead cells in U937-hGH cells treated with TNF-α compared to control cells.
- NF-κB activation was decreased in U937-hGH cells exposed to TNF-α.
- Exogenous hGH enhanced the sensitivity of U937 cells to TNF-α-induced apoptosis.
- Glutathione levels were higher in hGH-producing cells, suggesting a protective mechanism against apoptosis.
Takeaway
This study shows that human growth hormone can help cancer cells die when they are exposed to a specific signal, making it easier for treatments to work.
Methodology
The study used human myeloid leukaemia U937 cell lines and nude mice to assess the effects of hGH on apoptosis and NF-κB activity.
Potential Biases
Potential bias may arise from the use of specific cell lines and the controlled experimental conditions.
Limitations
The study was limited to specific cell lines and animal models, which may not fully represent human cancer biology.
Participant Demographics
The study involved human myeloid leukaemia U937 cell lines and nude mice.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website